{"ticker": {"uuid": "d5c72df2-758e-47dc-98ce-b2b00627d8ea", "symbol": "IBIO", "name": "iBio, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of \"Buy\" by Brokerages", "summary": "iBio, Inc. (NASDAQ:IBIO) has received a consensus \"Buy\" rating from eight brokerages, with an average 12-month price target of $5.00, despite a recent share price of $1.44. Analyst actions have been mixed, with some maintaining bullish ratings while others downgraded to \"sell.\" T", "url": "https://www.marketbeat.com/instant-alerts/ibio-inc-nasdaqibio-given-consensus-rating-of-buy-by-brokerages-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T08:12:12", "published_display": "15 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "iBio (NASDAQ:IBIO) Downgraded to \"Sell\" Rating by Wall Street Zen", "summary": "Wall Street Zen downgraded iBio (NASDAQ:IBIO) from a \"hold\" to a \"sell\" rating, though other analysts still predominantly rate the stock as \"buy\" with a consensus price target of $5.00. The company's stock remained flat at $1.51 on Friday, significantly below its 52-week high, an", "url": "https://www.marketbeat.com/instant-alerts/ibio-nasdaqibio-downgraded-to-sell-rating-by-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:40:40", "published_display": "12 Jul 2026 17:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think iBio (NASDAQ:IBIO) Can Afford To Drive Business Growth", "summary": "iBio (NASDAQ:IBIO), a biotech company that currently does not generate significant operating revenue, had a cash runway of about 3.4 years as of March 2026, with US$75m in cash and no debt. The company's cash burn increased by 41% in the last year to US$22m, indicating increased ", "url": "https://www.sahmcapital.com/news/content/we-think-ibio-nasdaqibio-can-afford-to-drive-business-growth-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-09T17:09:16", "published_display": "09 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides only the title \"Price to sales forward of iBio, Inc. \u2013 NASDAQ:IBIO\" and a table header \"Period Value Change Change %\" within the content. There is no accompanying financial data or analysis for iBio, Inc.'s price to sales forward metric. The majority of the ", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T19:39:13", "published_display": "05 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBIO - iBio Inc Latest SEC Filings", "summary": "This article provides the latest SEC filing information for iBio Inc (IBIO), including key financial metrics, stock performance data, insider and institutional ownership, and analyst recommendations. As of July 2nd, the stock closed at $1.68, down 4.00%, with a market cap of $83.", "url": "https://finviz.com/stock?t=IBIO&p=w&ty=lf&b=2&page=16", "source_name": "Finviz", "published_at": "2026-07-02T09:13:38", "published_display": "02 Jul 2026 09:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chardan Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5", "summary": "Chardan Capital has reiterated its 'Buy' rating for IBio Inc (IBIO.US) and maintained its target price of $5. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/72360552/chardan-capital-maintains-ibio-inc-ibious-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-02T03:39:13", "published_display": "02 Jul 2026 03:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$IBIO stock is up 13% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUld2MEpHSmJ2Y3NueHdQYnBDWGdJVlpjYVNuTEtHd1M2aHhzVUQ3cGR4a1NVUXpOb3J4c250QUVuWHN4VTJFdXBWYWNJYlF6azkya0x3OUVZbVlZSWd3cFh3UEhPRTg5UGVibTk4WU5SdllSRF9tMG9MRm40S1piZmJpOS1rUnRFWmRPOGNyb1h4ZVVTOWoxQTZ3UW1FTlB1?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-01T14:52:00+00:00", "published_display": "01 Jul 2026 14:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio (NASDAQ: IBIO) obesity antibody cuts Activin E and spares lean mass", "summary": "iBio (NASDAQ: IBIO) announced positive preclinical results for its IBIO-610 antibody, targeting Activin E for obesity and related diseases. In obese non-human primates, a single dose of IBIO-610 reduced active Activin E by up to 98% for eight weeks and, when combined with semaglu", "url": "https://www.stocktitan.net/sec-filings/IBIO/8-k-i-bio-inc-reports-material-event-a7097e9c3f4f.html", "source_name": "Stock Titan", "published_at": "2026-07-01T11:40:22", "published_display": "01 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio Reports Single Dose of IBIO-610 Achieved Near-Complete", "summary": "iBio, Inc. announced new preclinical data for its IBIO-610 antibody candidate, showing that a single dose achieved near-complete inhibition of active Activin E for eight weeks in obese non-human primates. When combined with semaglutide, IBIO-610 significantly increased visceral a", "url": "https://www.globenewswire.com/news-release/2026/07/01/3320497/0/en/ibio-reports-single-dose-of-ibio-610-achieved-near-complete-active-activin-e-inhibition-through-eight-weeks-in-obese-nhp-study.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T10:40:22", "published_display": "01 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBio, Inc.(NasdaqCM: IBIO) added to Russell Microcap Index", "summary": "iBio, Inc. (NasdaqCM: IBIO) has been added to the Russell Microcap Index, as announced on June 28, 2026. This inclusion reflects the company's standing in the financial markets. iBio is a biotechnology company focused on developing advanced biopharmaceuticals for various diseases", "url": "https://www.marketscreener.com/news/ibio-inc-nasdaqcm-ibio-added-to-russell-microcap-index-ce7f5fdcda8ef62d", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T16:12:51", "published_display": "30 Jun 2026 16:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides financial information for iBio, Inc. (NASDAQ: IBIO), specifically focusing on its enterprise value to EBIT forward metric. It appears to be a stub or a placeholder page from TradingView, indicating where this financial data would typically be displayed.", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T06:11:10", "published_display": "30 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides a brief overview of iBio, Inc. (NASDAQ: IBIO) with a focus on its price-to-book forward ratio. It appears to be a stub or a data-focused entry from TradingView, displaying financial metrics rather than an in-depth analysis. The content emphasizes financial d", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:05", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides financial information for iBio, Inc. (NASDAQ: IBIO) focusing on its enterprise value to revenue forward. The content is presented within the TradingView platform, offering various financial metrics and market data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:21", "published_display": "26 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "0JV0 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for iBio, Inc. (0JV0) stock, including analyst price targets and ratings. It details the company's past financial performance, future earnings and revenue expectations, and addresses frequently asked questions about its stock ticker, highest/lowes", "url": "https://www.tradingview.com/symbols/FWB-0JV0/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:10:03", "published_display": "26 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio Inc (IBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of iBio Inc.'s (IBIO) dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. However, it details several merger-related stock reverse splits that occurred in October 2023", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ibio/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:14", "published_display": "18 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $5", "summary": "Raymond James has initiated coverage on IBio Inc (IBIO.US) with a \"Buy\" rating. The firm has set a target price of $5 for the company's stock. This indicates a positive outlook from Raymond James regarding IBio Inc's future performance.", "url": "https://news.futunn.com/en/post/74272316/raymond-james-initiates-ibio-inc-ibious-with-buy-rating-announces", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-15T19:10:11", "published_display": "15 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could iBio (IBIO) Be an Underrated Obesity Stock?", "summary": "iBio, Inc. (NASDAQ:IBIO) is gaining attention as a potentially underrated obesity stock, with Raymond James initiating coverage with an Outperform rating and a $5 price target due to its emerging obesity-focused pipeline. The company recently dosed its first participant in a Phas", "url": "https://www.insidermonkey.com/blog/could-ibio-ibio-be-an-underrated-obesity-stock-1780088/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-11T20:37:00", "published_display": "11 Jun 2026 20:37", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Under-the-Radar AI Stocks to Buy in 2026", "summary": "This article identifies five under-the-radar AI stocks for investors to consider in 2026, including iBio, Inc., Veritone, Inc., Innodata Inc., Mitek Systems, Inc., and Lantronix, Inc. Each company is discussed with recent financial or operational updates, along with analyst opini", "url": "https://www.insidermonkey.com/blog/5-under-the-radar-ai-stocks-to-buy-in-2026-1778220/?singlepage=1", "source_name": "Insider Monkey", "published_at": "2026-06-11T16:33:00", "published_display": "11 Jun 2026 16:33", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About iBio's (NASDAQ:IBIO) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNYnIwNFVTZlVSSXFXdFhzOHI5OVI3Z2hleU8tLTlScXdLTzZ5RFI3ejBrQk5PNWdrVGVhcTQ2T1RoQnRzcUh6VTljMWN6NmFRTHpZZ3hwSmM2eVo0QWJ4UFBLdlE5YVp1ZWRTeTh5cVhGV3NYZUZFeDB5eWxhZWxfdDl3dkVHd2xzZ2NVR2NKS1lNS25MeVBv?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Insider Traders Lose US$19k As iBio Drops", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "IBIO Stock Is Soaring Today After iBio's Muscle-Preserving Drug Receives Approval For Human Trial In Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQdDl3Zk0yWlRRWGVHUFVjeEg1S2hkVFdHdjBWNHFqeDhKWS0xamJSdmV6V21jLUxUWDU4QU9pUnY4MzQxZjJNemtoeS1IWXU1cnJjVWhfMDNLNWhsUTVfdms1aUFnRGZkYzY2SkJpWHVSbXVQQTg1OFBmcG9iWUR6VXRBc3g2TEhVcmtNWVA5Rml4QWxnRzlmWUFDTHZIOFlJaGJDM2ZLQWZXUk5aUUlLVWZabXA0ODFVb2tyTkFuQUdiOUJiZ01UdFd0Qk0?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNUU0wS0NTdnRsdUE1UTJlMEYtN3J1RHpITHNaUFFxenVWaGdMNU9WVGNlWkFmWFIwcUlKN2wxQ3V4SGE4RDQtZVNRYVhxZWQ5ZTVtY0dmSEowb0FTZTBOaUtlSVRiZU9NODh5WjFyTFFjalFISm5qbFBTcmRYcDV5SzlkOHFjUmFseHM3d254WlZXd05sVkQyMENKc0pkVm81NngzY0hnYmdkMS1ndVo0QXR1WFNpR2d1Q3RTWTBkRTJ5TG8?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of \"Buy\" by Brokerages", "summary": "iBio, Inc. (NASDAQ:IBIO) has received a consensus \"Buy\" rating from eight brokerages, with an average 12-month price target of $5.00, despite a recent share price of $1.44. Analyst actions have been mixed, with some maintaining bullish ratings while others downgraded to \"sell.\" T", "url": "https://www.marketbeat.com/instant-alerts/ibio-inc-nasdaqibio-given-consensus-rating-of-buy-by-brokerages-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T08:12:12", "published_display": "15 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio (NASDAQ:IBIO) Downgraded to \"Sell\" Rating by Wall Street Zen", "summary": "Wall Street Zen downgraded iBio (NASDAQ:IBIO) from a \"hold\" to a \"sell\" rating, though other analysts still predominantly rate the stock as \"buy\" with a consensus price target of $5.00. The company's stock remained flat at $1.51 on Friday, significantly below its 52-week high, an", "url": "https://www.marketbeat.com/instant-alerts/ibio-nasdaqibio-downgraded-to-sell-rating-by-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:40:40", "published_display": "12 Jul 2026 17:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think iBio (NASDAQ:IBIO) Can Afford To Drive Business Growth", "summary": "iBio (NASDAQ:IBIO), a biotech company that currently does not generate significant operating revenue, had a cash runway of about 3.4 years as of March 2026, with US$75m in cash and no debt. The company's cash burn increased by 41% in the last year to US$22m, indicating increased ", "url": "https://www.sahmcapital.com/news/content/we-think-ibio-nasdaqibio-can-afford-to-drive-business-growth-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-09T17:09:16", "published_display": "09 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides only the title \"Price to sales forward of iBio, Inc. \u2013 NASDAQ:IBIO\" and a table header \"Period Value Change Change %\" within the content. There is no accompanying financial data or analysis for iBio, Inc.'s price to sales forward metric. The majority of the ", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T19:39:13", "published_display": "05 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBIO - iBio Inc Latest SEC Filings", "summary": "This article provides the latest SEC filing information for iBio Inc (IBIO), including key financial metrics, stock performance data, insider and institutional ownership, and analyst recommendations. As of July 2nd, the stock closed at $1.68, down 4.00%, with a market cap of $83.", "url": "https://finviz.com/stock?t=IBIO&p=w&ty=lf&b=2&page=16", "source_name": "Finviz", "published_at": "2026-07-02T09:13:38", "published_display": "02 Jul 2026 09:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chardan Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5", "summary": "Chardan Capital has reiterated its 'Buy' rating for IBio Inc (IBIO.US) and maintained its target price of $5. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/72360552/chardan-capital-maintains-ibio-inc-ibious-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-02T03:39:13", "published_display": "02 Jul 2026 03:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$IBIO stock is up 13% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUld2MEpHSmJ2Y3NueHdQYnBDWGdJVlpjYVNuTEtHd1M2aHhzVUQ3cGR4a1NVUXpOb3J4c250QUVuWHN4VTJFdXBWYWNJYlF6azkya0x3OUVZbVlZSWd3cFh3UEhPRTg5UGVibTk4WU5SdllSRF9tMG9MRm40S1piZmJpOS1rUnRFWmRPOGNyb1h4ZVVTOWoxQTZ3UW1FTlB1?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-01T14:52:00+00:00", "published_display": "01 Jul 2026 14:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio (NASDAQ: IBIO) obesity antibody cuts Activin E and spares lean mass", "summary": "iBio (NASDAQ: IBIO) announced positive preclinical results for its IBIO-610 antibody, targeting Activin E for obesity and related diseases. In obese non-human primates, a single dose of IBIO-610 reduced active Activin E by up to 98% for eight weeks and, when combined with semaglu", "url": "https://www.stocktitan.net/sec-filings/IBIO/8-k-i-bio-inc-reports-material-event-a7097e9c3f4f.html", "source_name": "Stock Titan", "published_at": "2026-07-01T11:40:22", "published_display": "01 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio Reports Single Dose of IBIO-610 Achieved Near-Complete", "summary": "iBio, Inc. announced new preclinical data for its IBIO-610 antibody candidate, showing that a single dose achieved near-complete inhibition of active Activin E for eight weeks in obese non-human primates. When combined with semaglutide, IBIO-610 significantly increased visceral a", "url": "https://www.globenewswire.com/news-release/2026/07/01/3320497/0/en/ibio-reports-single-dose-of-ibio-610-achieved-near-complete-active-activin-e-inhibition-through-eight-weeks-in-obese-nhp-study.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T10:40:22", "published_display": "01 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBio, Inc.(NasdaqCM: IBIO) added to Russell Microcap Index", "summary": "iBio, Inc. (NasdaqCM: IBIO) has been added to the Russell Microcap Index, as announced on June 28, 2026. This inclusion reflects the company's standing in the financial markets. iBio is a biotechnology company focused on developing advanced biopharmaceuticals for various diseases", "url": "https://www.marketscreener.com/news/ibio-inc-nasdaqcm-ibio-added-to-russell-microcap-index-ce7f5fdcda8ef62d", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T16:12:51", "published_display": "30 Jun 2026 16:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides financial information for iBio, Inc. (NASDAQ: IBIO), specifically focusing on its enterprise value to EBIT forward metric. It appears to be a stub or a placeholder page from TradingView, indicating where this financial data would typically be displayed.", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T06:11:10", "published_display": "30 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides a brief overview of iBio, Inc. (NASDAQ: IBIO) with a focus on its price-to-book forward ratio. It appears to be a stub or a data-focused entry from TradingView, displaying financial metrics rather than an in-depth analysis. The content emphasizes financial d", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:05", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of iBio, Inc. \u2013 NASDAQ:IBIO", "summary": "This article provides financial information for iBio, Inc. (NASDAQ: IBIO) focusing on its enterprise value to revenue forward. The content is presented within the TradingView platform, offering various financial metrics and market data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-IBIO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:21", "published_display": "26 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "0JV0 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for iBio, Inc. (0JV0) stock, including analyst price targets and ratings. It details the company's past financial performance, future earnings and revenue expectations, and addresses frequently asked questions about its stock ticker, highest/lowes", "url": "https://www.tradingview.com/symbols/FWB-0JV0/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:10:03", "published_display": "26 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iBio Inc (IBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of iBio Inc.'s (IBIO) dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. However, it details several merger-related stock reverse splits that occurred in October 2023", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ibio/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:14", "published_display": "18 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $5", "summary": "Raymond James has initiated coverage on IBio Inc (IBIO.US) with a \"Buy\" rating. The firm has set a target price of $5 for the company's stock. This indicates a positive outlook from Raymond James regarding IBio Inc's future performance.", "url": "https://news.futunn.com/en/post/74272316/raymond-james-initiates-ibio-inc-ibious-with-buy-rating-announces", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-15T19:10:11", "published_display": "15 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could iBio (IBIO) Be an Underrated Obesity Stock?", "summary": "iBio, Inc. (NASDAQ:IBIO) is gaining attention as a potentially underrated obesity stock, with Raymond James initiating coverage with an Outperform rating and a $5 price target due to its emerging obesity-focused pipeline. The company recently dosed its first participant in a Phas", "url": "https://www.insidermonkey.com/blog/could-ibio-ibio-be-an-underrated-obesity-stock-1780088/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-11T20:37:00", "published_display": "11 Jun 2026 20:37", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Under-the-Radar AI Stocks to Buy in 2026", "summary": "This article identifies five under-the-radar AI stocks for investors to consider in 2026, including iBio, Inc., Veritone, Inc., Innodata Inc., Mitek Systems, Inc., and Lantronix, Inc. Each company is discussed with recent financial or operational updates, along with analyst opini", "url": "https://www.insidermonkey.com/blog/5-under-the-radar-ai-stocks-to-buy-in-2026-1778220/?singlepage=1", "source_name": "Insider Monkey", "published_at": "2026-06-11T16:33:00", "published_display": "11 Jun 2026 16:33", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About iBio's (NASDAQ:IBIO) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNYnIwNFVTZlVSSXFXdFhzOHI5OVI3Z2hleU8tLTlScXdLTzZ5RFI3ejBrQk5PNWdrVGVhcTQ2T1RoQnRzcUh6VTljMWN6NmFRTHpZZ3hwSmM2eVo0QWJ4UFBLdlE5YVp1ZWRTeTh5cVhGV3NYZUZFeDB5eWxhZWxfdDl3dkVHd2xzZ2NVR2NKS1lNS25MeVBv?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Traders Lose US$19k As iBio Drops", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBIO Stock Is Soaring Today After iBio's Muscle-Preserving Drug Receives Approval For Human Trial In Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQdDl3Zk0yWlRRWGVHUFVjeEg1S2hkVFdHdjBWNHFqeDhKWS0xamJSdmV6V21jLUxUWDU4QU9pUnY4MzQxZjJNemtoeS1IWXU1cnJjVWhfMDNLNWhsUTVfdms1aUFnRGZkYzY2SkJpWHVSbXVQQTg1OFBmcG9iWUR6VXRBc3g2TEhVcmtNWVA5Rml4QWxnRzlmWUFDTHZIOFlJaGJDM2ZLQWZXUk5aUUlLVWZabXA0ODFVb2tyTkFuQUdiOUJiZ01UdFd0Qk0?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNUU0wS0NTdnRsdUE1UTJlMEYtN3J1RHpITHNaUFFxenVWaGdMNU9WVGNlWkFmWFIwcUlKN2wxQ3V4SGE4RDQtZVNRYVhxZWQ5ZTVtY0dmSEowb0FTZTBOaUtlSVRiZU9NODh5WjFyTFFjalFISm5qbFBTcmRYcDV5SzlkOHFjUmFseHM3d254WlZXd05sVkQyMENKc0pkVm81NngzY0hnYmdkMS1ndVo0QXR1WFNpR2d1Q3RTWTBkRTJ5TG8?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 84, "total_relevant": 41, "sentiment_summary": {"positive": 11, "negative": 3, "neutral": 27, "score": 57, "total": 41, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 74, "events": [{"event": "earnings", "label": "Earnings", "weight": 9.09, "count": 17}, {"event": "general", "label": "Market update", "weight": 7.5, "count": 13}, {"event": "analyst", "label": "Analyst action", "weight": 3.85, "count": 7}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 1.51, "latest_week": "2026-07-10", "one_week_move": -10.1, "four_week_move": -10.7, "twelve_week_move": -26.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.602236, "market_dynamics_buy_signal": false, "relative_strength": -17.346224, "fair_value_gap": -40.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.1705, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.1% over one week, -10.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "TradingView", "count": 7}, {"label": "simplywall.st", "count": 3}, {"label": "MarketBeat", "count": 2}, {"label": "Quiver Quantitative", "count": 2}, {"label": "Insider Monkey", "count": 2}, {"label": "Stocktwits", "count": 2}, {"label": "TIKR.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 34}, {"label": "Industry context", "count": 7}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 17}, {"label": "Market update", "count": 13}, {"label": "Analyst action", "count": 7}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "34", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.1% over one week, -10.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of \"Buy\" by Brokerages"}], "updated_at": "2026-07-16T04:34:45.937327+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}